Facebook Twitter LinkedIn Google Plus RSS

Actavis, Medicines360 announce partnership on birth control

Parsippany-based pharmaceutical company Actavis Inc. and California-based Medicines360, a nonprofit pharmaceutical company, announced Tuesday a partnership to support Medicines360’s mission to reduce cost as a barrier to accessing birth control.

According to the announcement, the Medicines360 and Actavis partnership will make the intrauterine devices available at low prices in U.S. public sector clinics. Terms were not disclosed.

Also Popular on NJBIZ

Leave a Comment


Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
View Comment Policy